HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $599,969 | +2.8% | 15,706 | -3.0% | 0.39% | +14.5% |
| Q2 2023 | $583,829 | -20.1% | 16,186 | -15.5% | 0.34% | -13.6% |
| Q1 2023 | $731,109 | -32.9% | 19,144 | 0.0% | 0.39% | -22.0% |
| Q4 2022 | $1,089,294 | +25.8% | 19,144 | -12.6% | 0.50% | +11.6% |
| Q3 2022 | $866,000 | -10.2% | 21,901 | 0.0% | 0.45% | -4.5% |
| Q2 2022 | $964,000 | +5.8% | 21,901 | -4.1% | 0.47% | +26.0% |
| Q1 2022 | $911,000 | -3.6% | 22,831 | -2.9% | 0.37% | -1.6% |
| Q4 2021 | $945,000 | -3.2% | 23,511 | -2.0% | 0.38% | -13.5% |
| Q3 2021 | $976,000 | – | 23,996 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |